arXiv subjects

Shahram Taeb

Publications and source records attributed to Shahram Taeb.

6 recordsLinked to original sources

arXiv2026

A Clinically Anchored Radiomics Dictionary for Explainable TI-RADS-Based Thyroid Nodule Classification in Ultrasound; Dictionary Version TU1.0

Artificial intelligence based radiomics models for thyroid ultrasound (US) often achieve strong diagnostic performance but remain difficult to interpret, limiting clinical trust and adoption. We developed and validated an interpretable radiomic feature (RF) framework for thyroid nodule classification by linking quantitative US features to the Thyroid Imaging Reporting and Data System (TI-RADS) semantic lexicon through a clinically grounded radiomics dictionary. The dictionary mapped TI-RADS categories, including composition, echogenicity, shape, margin, and echogenic foci, to Image Biomarker Standardization Initiative compliant RFs extracted from two-dimensional US images. Relationships were defined through expert consensus and examined using Shapley Additive Explanations (SHAP). Three multicenter datasets were combined, yielding 5,542 nodules. A total of 107 RFs were extracted using PyRadiomics and normalized with min-max scaling. For benign versus malignant classification, 27 feature selection methods were paired with 25 classifiers and evaluated using stratified five-fold cross-validation on 70% of the data, followed by testing on the remaining 30%. Robust model selection used a stability-aware composite score combining mean performance and variability across balanced accuracy, precision, recall, F1-score, and ROC-AUC. The proposed dictionary enabled direct interpretation of radiomic signatures in TI-RADS terms. The best model, Select-From-Model based on logistic regression with Extra-Trees, achieved a test ROC-AUC of 0.941 +/- 0.005. SHAP analysis showed that texture heterogeneity was the dominant malignancy signal, with gray level run length matrix non-uniformity, intensity dispersion, and kurtosis aligning with high-risk TI-RADS descriptors. These findings support transparent and clinically meaningful thyroid nodule risk stratification from US.

physics.med-ph↗

arXiv2025

Towards Interpretable AI in Personalized Medicine: A Radiological-Biological Radiomics Dictionary Connecting Semantic Lung-RADS and imaging Radiomics Features; Dictionary LC 1.0

Lung cancer remains the leading cause of cancer-related mortality worldwide, with survival strongly dependent on early detection. Standard-dose computed tomography (CT) screening using the Lung Imaging Reporting and Data System (Lung-RADS) standardizes pulmonary nodule assessment but is limited by inter-reader variability and reliance on qualitative descriptors, while radiomics offers quantitative biomarkers that often lack clinical interpretability. To bridge this gap, we propose a radiological-biological dictionary that aligns radiomic features (RFs) with Lung-RADS semantic categories. A clinically informed dictionary translating ten Lung-RADS descriptors into radiomic proxies was developed through literature curation and validated by eight expert reviewers. As a proof of concept, imaging and clinical data from 977 patients across 12 collections in The Cancer Imaging Archive (TCIA) were analyzed; following preprocessing and manual segmentation, 110 RFs per nodule were extracted using PyRadiomics in compliance with the Image Biomarker Standardization Initiative (IBSI). A semi-supervised learning framework incorporating 499 labeled and 478 unlabeled cases was applied to improve generalizability, evaluating seven feature selection methods and ten interpretable classifiers. The optimal pipeline (ANOVA feature selection with a support vector machine) achieved a mean validation accuracy of 0.79. SHapley Additive exPlanations (SHAP) analysis identified key RFs corresponding to Lung-RADS semantics such as attenuation, margin irregularity, and spiculation, supporting the validity of the proposed mapping. Overall, this dictionary provides an interpretable framework linking radiomics and Lung-RADS semantics, advancing explainable artificial intelligence for CT-based lung cancer screening.

physics.med-ph↗

arXiv2025

Semi-Supervised Radiomics for Glioblastoma IDH Mutation: Limited Labels, Data Sensitivity, and SHAP Interpretation

Glioblastoma (GBM) is an aggressive brain tumor in which IDH mutation status is a key prognostic biomarker, but traditional testing requires invasive biopsies, emphasizing the need for non-invasive approaches. In this multi-center study, we analyzed MRI sequences (T1, T2-weighted, contrast-enhanced T1, and FLAIR) from 1,329 patients across eight centers, with IDH labels available for 1,061 cases. A total of 1,223 radiomic features per case were extracted using PyRadiomics with Laplacian of Gaussian and wavelet filters, and both supervised learning (SL) and semi-supervised learning (SSL) frameworks were applied, incorporating 38 feature selection/attribute extraction strategies and 24 classifiers. Five-fold cross-validation was performed on UCSF-PDGM and UPENN datasets, and external validation on IvyGAP, TCGA-LGG, and TCGA-GBM, with SHAP analysis conducted for feature interpretability. Multimodal MRI fusion (T1+T2+T1CE+FLAIR) consistently outperformed single-sequence models. The best SSL model (RFE + SVM) achieved 0.93 cross-validation and 0.75 external accuracy, while the top SL model (RFE + Complement Naive Bayes) reached 0.90 and 0.80, respectively. SSL further demonstrated greater robustness to limited sample sizes, maintaining stable performance compared to SL, and SHAP analysis highlighted the amplified role of first-order Root Mean Square (T1CE) and wavelet-based features, strengthening biomarker interpretability. These findings indicate that SSL enhances accuracy, stability, and interpretability in MRI-based IDH prediction, with multimodal MRI fusion providing the most scalable and reliable strategy for non-invasive biomarker discovery in GBM.

physics.med-ph↗

arXiv2025

Enhancement Without Contrast: Stability-Aware Multicenter Machine Learning for Glioma MRI Imaging

Gadolinium-based contrast agents (GBCAs) are central to glioma imaging but raise safety, cost, and accessibility concerns. Predicting contrast enhancement from non-contrast MRI using machine learning (ML) offers a safer alternative, as enhancement reflects tumor aggressiveness and informs treatment planning. Yet scanner and cohort variability hinder robust model selection. We propose a stability-aware framework to identify reproducible ML pipelines for multicenter prediction of glioma MRI contrast enhancement. We analyzed 1,446 glioma cases from four TCIA datasets (UCSF-PDGM, UPENN-GB, BRATS-Africa, BRATS-TCGA-LGG). Non-contrast T1WI served as input, with enhancement derived from paired post-contrast T1WI. Using PyRadiomics under IBSI standards, 108 features were extracted and combined with 48 dimensionality reduction methods and 25 classifiers, yielding 1,200 pipelines. Rotational validation was trained on three datasets and tested on the fourth. Cross-validation prediction accuracies ranged from 0.91 to 0.96, with external testing achieving 0.87 (UCSF-PDGM), 0.98 (UPENN-GB), and 0.95 (BRATS-Africa), with an average of 0.93. F1, precision, and recall were stable (0.87 to 0.96), while ROC-AUC varied more widely (0.50 to 0.82), reflecting cohort heterogeneity. The MI linked with ETr pipeline consistently ranked highest, balancing accuracy and stability. This framework demonstrates that stability-aware model selection enables reliable prediction of contrast enhancement from non-contrast glioma MRI, reducing reliance on GBCAs and improving generalizability across centers. It provides a scalable template for reproducible ML in neuro-oncology and beyond.

cs.CV↗

arXiv2025

Handcrafted vs. Deep Radiomics vs. Fusion vs. Deep Learning: A Comprehensive Review of Machine Learning -Based Cancer Outcome Prediction in PET and SPECT Imaging

Machine learning (ML), including deep learning (DL) and radiomics-based methods, is increasingly used for cancer outcome prediction with PET and SPECT imaging. However, the comparative performance of handcrafted radiomics features (HRF), deep radiomics features (DRF), DL models, and hybrid fusion approaches remains inconsistent across clinical applications. This systematic review analyzed 226 studies published from 2020 to 2025 that applied ML to PET or SPECT imaging for outcome prediction. Each study was evaluated using a 59-item framework covering dataset construction, feature extraction, validation methods, interpretability, and risk of bias. We extracted key details including model type, cancer site, imaging modality, and performance metrics such as accuracy and area under the curve (AUC). PET-based studies (95%) generally outperformed those using SPECT, likely due to higher spatial resolution and sensitivity. DRF models achieved the highest mean accuracy (0.862), while fusion models yielded the highest AUC (0.861). ANOVA confirmed significant differences in performance (accuracy: p=0.0006, AUC: p=0.0027). Common limitations included inadequate handling of class imbalance (59%), missing data (29%), and low population diversity (19%). Only 48% of studies adhered to IBSI standards. These findings highlight the need for standardized pipelines, improved data quality, and explainable AI to support clinical integration.

physics.med-ph↗

arXiv2025

Robust Semi-Supervised CT Radiomics for Lung Cancer Prognosis: Cost-Effective Learning with Limited Labels and SHAP Interpretation

Background: CT imaging is vital for lung cancer management, offering detailed visualization for AI-based prognosis. However, supervised learning SL models require large labeled datasets, limiting their real-world application in settings with scarce annotations. Methods: We analyzed CT scans from 977 patients across 12 datasets extracting 1218 radiomics features using Laplacian of Gaussian and wavelet filters via PyRadiomics Dimensionality reduction was applied with 56 feature selection and extraction algorithms and 27 classifiers were benchmarked A semi supervised learning SSL framework with pseudo labeling utilized 478 unlabeled and 499 labeled cases Model sensitivity was tested in three scenarios varying labeled data in SL increasing unlabeled data in SSL and scaling both from 10 percent to 100 percent SHAP analysis was used to interpret predictions Cross validation and external testing in two cohorts were performed. Results: SSL outperformed SL, improving overall survival prediction by up to 17 percent. The top SSL model, Random Forest plus XGBoost classifier, achieved 0.90 accuracy in cross-validation and 0.88 externally. SHAP analysis revealed enhanced feature discriminability in both SSL and SL, especially for Class 1 survival greater than 4 years. SSL showed strong performance with only 10 percent labeled data, with more stable results compared to SL and lower variance across external testing, highlighting SSL's robustness and cost effectiveness. Conclusion: We introduced a cost-effective, stable, and interpretable SSL framework for CT-based survival prediction in lung cancer, improving performance, generalizability, and clinical readiness by integrating SHAP explainability and leveraging unlabeled data.

physics.med-ph↗